Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FYBGE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from its Park Ridge, Illinois facility, leveraging its established position as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, featuring a 30-month base period with three 30-month option periods. The PPV-G GEN V represents a broader $30.3 billion federal acquisition strategy designed to ensure the Department of Defense has access to comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide, with DMS Pharmaceutical Group positioned as one of multiple regional prime vendor contractors under this program.
Quick answers
Who was awarded contract SPE2DB26FYBGE?
SPE2DB26FYBGE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FYBGE worth?
The government has obligated $12,116 on SPE2DB26FYBGE.
Is contract SPE2DB26FYBGE an order under another contract?
Yes. SPE2DB26FYBGE is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB26FYBGE competed?
The extent of competition for SPE2DB26FYBGE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award